COVID-19 Monoclonal antibody use in post-acute, long-term care settings

COVID-19 Monoclonal antibody use in post-acute, long-term care settings

presented by CMDA, mAb Colorado, and CDPHE

     Monday, September 13, 2021 

     4:00pm – 5:00pm MT

     RSVP Here

The aim of the CMDA-mAb Colorado webinar is to learn clinical evidence for mAb (monoclonal antibody) use as both treatment and post-exposure prophylaxis, how Colorado long-term care providers are currently using mAbs, and what is needed to increase use of mAbs in Colorado long-term care communities.

The CMDA COVID-19 monoclonal antibody webinar will be completely online.

Intended audience: This webinar will be tailored for physicians, physician assistants, nurse practitioners, medical directors, pharmacists, and other professionals in long-term

Moderators: Leslie Eber, MD, CMD and Sing Palat, MD, CMD

Presenters/panelists:

• Diana Tapay, MD
• Hillary Lum, MD PhD
• Allison Villegas, PA-C
• Jennifer Connelly, PharmD, BCACP, BCGP
• Bethany Kwan, PhD
• Clay Watson, MD

Outline:

1. Introduction
2. Significance and current need for mAb
3. Clinical evidence for mAb use, eligibility
4. Protocols for mAb use
5. How the LTC pharmacy can help
6. Arranging mAb treatment outside of LTC facilities
7. Panel discussion
8. Wrap up

Resources on COVID-19 monoclonal antibody

• https://medschool.cuanschutz.edu/mab-colorado
• • mAb Colorado website
• https://covid19.colorado.gov/for-coloradans/covid-19-treatments
• • CDPHE COVID monoclonal antibody website
• Best Practices for Use of Monoclonal Antibodies to Treat COVID_8_31-21.pdf (paltc.org)
  
• • AMDA Document on Best practices 8.31.21